Accel Research-Birmingham Clinical Research Unit — Birmingham, Alabama

Accel Research-Birmingham Clinical Research Unit is a clinical research site located in Birmingham, Alabama, United States 35216.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Accel Research-Birmingham Clinical Research Unit has participated in 1 clinical trials.

Therapeutic areas: Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID.

Sponsors: Tonix Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accel Research-Birmingham Clinical Research Unit?

Accel Research-Birmingham Clinical Research Unit has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accel Research-Birmingham Clinical Research Unit conducted?

Accel Research-Birmingham Clinical Research Unit has 1 clinical trials on record. Their work covers Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection, COVID-19, Long COVID.

Is Accel Research-Birmingham Clinical Research Unit accredited by Crixeo Health?

Accel Research-Birmingham Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accel Research-Birmingham Clinical Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.